The Sialic acids on tumor cells activate the Siglec‐G‐SHP2 axis in CD8+ T cells, impairing the metabolic reprogramming from oxidative phosphorylation to glycolysis and consequently dampening CTL activation, expansion, and cytotoxicity. The gene discussed is CD8A; the disease is neoplasm.